Never Run Out Of Buyers To Sell To.

Advanced Therapies is a cell therapy Contract Testing, Development and Manufacturing Organization (CTDMO.) We leverage our significant experience and proven track record in development and manufacturing, as well as expert testing services, to enable advanced therapies to be developed, manufactured and released faster and with greater predictability, thereby reducing the complexities and cost of high-touch, multi-vendor production models. On 7 March 2025, Advanced Therapies U.S. and our discovery arm, OXGENE were purchased by Altaris, an investment firm headquartered in the U.S. with an…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$250M to $500M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.